Figure 3 | Scientific Reports

Figure 3

From: Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy

Figure 3

NIS protein and NIS mRNA in EVs from NIS-expressing cancer cells. (A) Western blots and quantified band intensities of NIS (top) and CD63 protein (bottom, control) in EVs derived from Huh7, Huh7/NIS-Adv, MDAMB231, and MDAMB/NIS-stable donor cells. (B) RT-PCR for NIS mRNA (top) and GADPH mRNA (bottom, control) in EVs from respective donor cells. MDAMB231 and MDAMB231/NIS-stable cells were used for NIS mRNA negative control (NC) and positive control (PC), respectively.

Back to article page